Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
1.280
-0.080 (-5.88%)
At close: Oct 31, 2024, 4:00 PM
1.300
+0.020 (1.56%)
After-hours: Oct 31, 2024, 5:12 PM EDT
Adicet Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Revenue | - | - | 24.99 | 9.73 | 17.9 | 1 | Upgrade
|
Revenue Growth (YoY) | - | - | 156.83% | -45.65% | 1699.30% | -87.84% | Upgrade
|
Gross Profit | - | - | 24.99 | 9.73 | 17.9 | 1 | Upgrade
|
Selling, General & Admin | 27.36 | 26.53 | 26.3 | 22.22 | 15.66 | 8.69 | Upgrade
|
Research & Development | 100.72 | 106.04 | 71.25 | 47.75 | 33.93 | 23.69 | Upgrade
|
Operating Expenses | 128.08 | 132.58 | 97.54 | 69.97 | 49.59 | 32.38 | Upgrade
|
Operating Income | -128.08 | -132.58 | -72.55 | -60.24 | -31.69 | -31.39 | Upgrade
|
Interest Expense | -0 | -0.03 | -0.08 | -0.18 | -0.13 | - | Upgrade
|
Interest & Investment Income | 10.62 | 9.98 | 3.76 | 0.09 | 0.79 | 0.94 | Upgrade
|
Other Non Operating Income (Expenses) | -0.36 | -0.57 | -0.92 | -0.61 | -0.95 | 2.33 | Upgrade
|
EBT Excluding Unusual Items | -117.83 | -123.2 | -69.79 | -60.93 | -31.99 | -28.12 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | -7.1 | - | Upgrade
|
Impairment of Goodwill | -19.46 | -19.46 | - | - | - | - | Upgrade
|
Asset Writedown | - | - | - | -1.19 | -2.3 | - | Upgrade
|
Other Unusual Items | - | - | - | - | 1.9 | - | Upgrade
|
Pretax Income | -137.29 | -142.66 | -69.79 | -62.12 | -39.49 | -28.12 | Upgrade
|
Income Tax Expense | - | - | - | -0.13 | -2.82 | 0.02 | Upgrade
|
Net Income | -137.29 | -142.66 | -69.79 | -62 | -36.68 | -28.14 | Upgrade
|
Net Income to Common | -137.29 | -142.66 | -69.79 | -62 | -36.68 | -28.14 | Upgrade
|
Shares Outstanding (Basic) | 64 | 43 | 41 | 31 | 7 | 2 | Upgrade
|
Shares Outstanding (Diluted) | 64 | 43 | 41 | 31 | 7 | 2 | Upgrade
|
Shares Change (YoY) | 50.31% | 4.78% | 32.72% | 322.84% | 242.22% | 9.86% | Upgrade
|
EPS (Basic) | -2.15 | -3.31 | -1.70 | -2.00 | -5.01 | -13.15 | Upgrade
|
EPS (Diluted) | -2.15 | -3.31 | -1.70 | -2.00 | -5.01 | -13.15 | Upgrade
|
Free Cash Flow | -92.58 | -98.18 | -61.55 | -64.1 | -42.54 | -28.95 | Upgrade
|
Free Cash Flow Per Share | -1.45 | -2.28 | -1.50 | -2.07 | -5.81 | -13.54 | Upgrade
|
Gross Margin | - | - | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
Operating Margin | - | - | -290.32% | -619.15% | -177.02% | -3154.57% | Upgrade
|
Profit Margin | - | - | -279.27% | -637.19% | -204.87% | -2827.94% | Upgrade
|
Free Cash Flow Margin | - | - | -246.29% | -658.77% | -237.62% | -2909.75% | Upgrade
|
EBITDA | -121.5 | -126.48 | -69.98 | -58.71 | -30.47 | -30.15 | Upgrade
|
EBITDA Margin | - | - | -280.02% | - | -170.17% | - | Upgrade
|
D&A For EBITDA | 6.59 | 6.1 | 2.58 | 1.54 | 1.23 | 1.24 | Upgrade
|
EBIT | -128.08 | -132.58 | -72.55 | -60.24 | -31.69 | -31.39 | Upgrade
|
EBIT Margin | - | - | -290.32% | - | -177.01% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.